WhatsApp
backNews Article

Ipca Laboratories Posts ₹2,909.94 Crore Standalone Revenue and ₹375.13 Crore Net Profit for Quarter Ended September 2026

Company also reports consolidated net profit of ₹387.29 crore for Q2 and ₹760.58 crore for half year ended September 30, 2026

Ipca Laboratories Limited released its unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2026, reporting total income from operations of ₹2,909.94 crore standalone and ₹2,255.61 crore consolidated for the quarter, with net profits after tax of ₹375.13 crore standalone and ₹387.29 crore consolidated for the quarter.

5 hours ago|IPCALAB-0.40%
Ipca Laboratories Limited524494IPCALABGeneral / Other

Ipca Laboratories Limited

General / Other

Ipca Laboratories Limited declared its unaudited financial results for the second quarter and half year ended September 30, 2026, showing increased total income and net profits both on a standalone and consolidated basis.

The standalone total income from operations for the second quarter was ₹2,909.94 crore, compared to ₹2,556.50 crore in the same quarter of the previous year. Net profit after tax for the quarter stood at ₹375.13 crore, up from ₹282.57 crore in the corresponding period last year.

On a consolidated basis, the company reported total income from operations of ₹2,255.61 crore for the quarter ended September 30, 2026, with a net profit after tax of ₹387.29 crore.

For the half year ended September 30, 2026, standalone total income was ₹5,698.04 crore with net profit after tax amounting to ₹777.02 crore. Consolidated income for the half year was ₹4,374.85 crore, with net profit after tax of ₹760.58 crore.

The financial results were reviewed by the Audit Committee and approved by the Board on November 5, 2026. The statutory auditors conducted a limited review and issued an unmodified report.

The company’s equity share capital remains constant at ₹25.37 crore in standalone and ₹25.37 crore in consolidated financials.

Highlights

  • Standalone total income from operations was ₹2,909.94 crore in Q2 September 2026.
  • Standalone net profit after tax reached ₹375.13 crore for Q2 September 2026.
  • Consolidated total income was ₹2,255.61 crore for the same period.
  • Consolidated net profit after tax stood at ₹387.29 crore for Q2.
  • Standalone total income for half year ended September 2026 was ₹5,698.04 crore.
  • Standalone net profit after tax for half year was ₹777.02 crore.

Key Data Snapshot

Standalone Total Income (Q2 ended September 30, 2026)₹2,909.94 crore
Standalone Net Profit after Tax (Q2 ended September 30, 2026)₹375.13 crore
Consolidated Total Income (Q2 ended September 30, 2026)₹2,255.61 crore
Consolidated Net Profit after Tax (Q2 ended September 30, 2026)₹387.29 crore
Standalone Total Income (Half Year ended September 30, 2026)₹5,698.04 crore
Standalone Net Profit after Tax (Half Year ended September 30, 2026)₹777.02 crore
Consolidated Total Income (Half Year ended September 30, 2026)₹4,374.85 crore
Consolidated Net Profit after Tax (Half Year ended September 30, 2026)₹760.58 crore
Equity Share Capital₹25.37 crore

What happened

  • Ipca Laboratories Limited announced its unaudited standalone and consolidated financial results for Q2 and half year ended September 30, 2026.
  • The results were reviewed by the Audit Committee, approved by the Board of Directors on November 5, 2026, and have been subjected to limited review by statutory auditors.
  • The company’s equity share capital remained unchanged at ₹25.37 crore.

Key details

  • Standalone total income for the quarter was ₹2,909.94 crore, higher than ₹2,556.50 crore in Q2 of previous year.
  • Standalone net profit after tax for the quarter was ₹375.13 crore, compared to ₹282.57 crore in the same quarter last year.
  • Consolidated total income for the quarter reached ₹2,255.61 crore, with net profit after tax of ₹387.29 crore.
  • For the half year, standalone total income was ₹5,698.04 crore with net profit after tax of ₹777.02 crore.
  • Consolidated total income for half year was ₹4,374.85 crore and net profit after tax stood at ₹760.58 crore.

More News on General / Other

View all

Latest corporate announcements and market updates in General / Other.

View all news
Ipca Laboratories Posts ₹2,909.94 Crore Standalone | Stockk News